# Ellington Credit Co: financial statements, quarterly

EARN · NYSE · CIK 1560672 · [Real estate](/sectors/real-estate.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/earn.md) · [Financials](/companies/earn/financials.md) · [Filings](/companies/earn/filings.md) · [Insiders](/companies/earn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/earn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q2 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q1 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q4 FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | [4.3](/filings/0001560672-23-000083.md) | [7.5 d](/filings/0001560672-24-000017.md) | [9.7](/filings/0001560672-24-000045.md) | [11.7](/filings/0001560672-24-000080.md) | [12.3](/filings/0001560672-24-000143.md) | [11.5 d](/filings/0001560672-25-000074.md) | [10.1](/filings/0001560672-25-000074.md) | [10.2](/filings/0001560672-24-000080.md) | [7.8](/filings/0001560672-24-000143.md) | [6.7 d](/filings/0001560672-25-000074.md) | [6.2](/filings/0001560672-25-000074.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0001560672-24-000045.md) | [0.0](/filings/0001560672-24-000080.md) | [0.0](/filings/0001560672-24-000143.md) | [0.0 d](/filings/0001560672-25-000074.md) | [0.3](/filings/0001560672-25-000074.md) | [(0.1)](/filings/0001560672-24-000080.md) | [0.5](/filings/0001560672-24-000143.md) | [(0.2) d](/filings/0001560672-25-000074.md) | [(0.0)](/filings/0001560672-25-000074.md) |
| Net income | $m | [(10.7)](/filings/0001560672-23-000083.md) | [(13.7)](/filings/0001560672-23-000083.md) | [11.7 d](/filings/0001560672-24-000017.md) | [2.3](/filings/0001560672-24-000143.md) | [1.2](/filings/0001560672-24-000143.md) | [(11.4)](/filings/0001560672-24-000143.md) | [12.4 d](/filings/0001560672-25-000074.md) | [4.0](/filings/0001560672-25-000074.md) | [(0.8)](/filings/0001560672-24-000143.md) | [5.4](/filings/0001560672-24-000143.md) | [(2.0) d](/filings/0001560672-25-000074.md) | [(7.9)](/filings/0001560672-25-000074.md) |
| Basic EPS | $ per share | [(0.82)](/filings/0001560672-23-000061.md) | [(1.04)](/filings/0001560672-23-000083.md) | not reported | [0.17](/filings/0001560672-24-000045.md) | [0.09](/filings/0001560672-24-000080.md) | [(0.75)](/filings/0001560672-24-000143.md) | not reported | [0.20](/filings/0001560672-25-000074.md) | [(0.04)](/filings/0001560672-24-000080.md) | [0.21](/filings/0001560672-24-000143.md) | not reported | [(0.23)](/filings/0001560672-25-000074.md) |

- Cost of revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q2 FY2022 (2022-09-30) | FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q1 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [37.5](/filings/0001560672-23-000061.md) | [25.4](/filings/0001560672-23-000083.md) | [34.8](/filings/0001560672-25-000074.md) | [36.7](/filings/0001560672-24-000045.md) | [43.7](/filings/0001560672-24-000080.md) | [40.0](/filings/0001560672-24-000143.md) | [38.5](/filings/0001560672-25-000074.md) | [22.4](/filings/0001560672-25-000074.md) | [119](/filings/0001560672-24-000080.md) | [25.7](/filings/0001560672-24-000143.md) | [31.8](/filings/0001560672-25-000074.md) | [17.4](/filings/0001560672-25-000074.md) |
| Total assets | $m | [1,122](/filings/0001560672-22-000044.md) | [1,189](/filings/0001560672-22-000056.md) | [1,054](/filings/0001560672-24-000017.md) | [1,124](/filings/0001560672-23-000046.md) | [1,084](/filings/0001560672-23-000061.md) | [1,064](/filings/0001560672-23-000083.md) | [946](/filings/0001560672-25-000074.md) | [964](/filings/0001560672-24-000045.md) | [933](/filings/0001560672-24-000080.md) | [752](/filings/0001560672-24-000143.md) | [824](/filings/0001560672-25-000074.md) | [784](/filings/0001560672-25-000074.md) |
| Total liabilities | $m | [1,003](/filings/0001560672-22-000044.md) | [1,086](/filings/0001560672-22-000056.md) | [941](/filings/0001560672-24-000017.md) | [1,009](/filings/0001560672-23-000046.md) | [967](/filings/0001560672-23-000061.md) | [953](/filings/0001560672-23-000083.md) | [809](/filings/0001560672-25-000074.md) | [821](/filings/0001560672-24-000045.md) | [787](/filings/0001560672-24-000080.md) | [561](/filings/0001560672-24-000143.md) | [630](/filings/0001560672-25-000074.md) | [555](/filings/0001560672-25-000074.md) |
| Shareholders' equity | $m | [119](/filings/0001560672-23-000083.md) | [103](/filings/0001560672-23-000083.md) | [112](/filings/0001560672-25-000074.md) | [115](/filings/0001560672-24-000143.md) | [117](/filings/0001560672-24-000143.md) | [111](/filings/0001560672-24-000143.md) | [136](/filings/0001560672-25-000074.md) | [143](/filings/0001560672-25-000074.md) | [146](/filings/0001560672-24-000143.md) | [192](/filings/0001560672-24-000143.md) | [194](/filings/0001560672-25-000074.md) | [229](/filings/0001560672-25-000074.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q4 FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [7,138 d](/filings/0001560672-23-000061.md) | [4,176 d](/filings/0001560672-23-000083.md) | [4,211 d](/filings/0001560672-24-000017.md) | [(2,383)](/filings/0001560672-24-000045.md) | [(1,998) d](/filings/0001560672-24-000080.md) | [(3,367) d](/filings/0001560672-24-000143.md) | [(2,274) d](/filings/0001560672-25-000074.md) | [(1,205)](/filings/0001560672-25-000074.md) | [2,670 d](/filings/0001560672-24-000080.md) | [3,241 d](/filings/0001560672-24-000143.md) | [4,406 d](/filings/0001560672-25-000074.md) | [9,211](/filings/0001560672-25-000074.md) |
| Dividends paid | $k | [3,671 d](/filings/0001560672-23-000061.md) | [3,151 d](/filings/0001560672-23-000083.md) | [3,182 d](/filings/0001560672-24-000017.md) | [3,269](/filings/0001560672-24-000045.md) | [3,328 d](/filings/0001560672-24-000080.md) | [3,617 d](/filings/0001560672-24-000143.md) | [3,908 d](/filings/0001560672-25-000074.md) | [4,659](/filings/0001560672-25-000074.md) | [4,834 d](/filings/0001560672-24-000080.md) | [5,877 d](/filings/0001560672-24-000143.md) | [6,845 d](/filings/0001560672-25-000074.md) | [8,082](/filings/0001560672-25-000074.md) |
| Share repurchases | $k | not reported | [62.0 d](/filings/0001560672-23-000083.md) | [0.0 d](/filings/0001560672-24-000017.md) | not reported | not reported | [0.0 d](/filings/0001560672-23-000083.md) | [0.0 d](/filings/0001560672-25-000074.md) | [0.0](/filings/0001560672-25-000074.md) | not reported | not reported | not reported | [978](/filings/0001560672-25-000074.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 37,559,195 at 2025-06-06, from the cover of the [10-K filed 2025-06-23](/filings/0001560672-25-000074.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.